Patents by Inventor Martin KATO

Martin KATO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11952386
    Abstract: The present invention relates to compounds of formula I: in which p, q, Y1, Y2, R1, R2a, R2b, R3a, R3b, R4a, R4b, R5a, R5b, R7 and R8 are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.
    Type: Grant
    Filed: February 23, 2021
    Date of Patent: April 9, 2024
    Assignee: NOVARTIS AG
    Inventors: Christine Hiu-Tung Chen, Zhuoliang Chen, Michael Dore, Jorge Garcia Fortanet, John William Giraldes, Rajesh Karki, Mitsunori Kato, Matthew J. LaMarche, Lawrence Blas Perez, Martin Sendzik, Troy Douglas Smith, Bakary-Barry Toure, Sarah Williams
  • Publication number: 20160146709
    Abstract: A method includes receiving, at computing system, sensor data from a machine, preparing the sensor data for use by data mining algorithms, generating an analysis table based on the prepared sensor data, the analysis table including information and data for a plurality of instances for the machine, and using the information and data included in the analysis table to predict a failure of the machine.
    Type: Application
    Filed: November 21, 2014
    Publication date: May 26, 2016
    Inventors: Satyadeep DEY, Markus DOEHRING, Martin KATO, Jaakob KIND, Gudrun KLOSE, Robert LANG, Uta Maria LOESCH, Christine PREISACH, Christian THEILEMANN